Form 6-K ALTERITY THERAPEUTICS For: Nov 10

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-163

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 10, 2025

 

Alterity Therapeutics Limited

(Name of Registrant)

 

Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980 and 333-228671) and our Registration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417 and 333-250076)

 

 

 

ALTERITY THERAPEUTICS LIMITED

(a development stage enterprise)

 

The following exhibits are submitted:

 

99.1

Alterity Presents Promising ATH434 Impact at AAS Symposium

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Alterity Therapeutics Limited
	By:	/s/ Geoffrey P. Kempler
		Geoffrey P. Kempler
		Chairman

 

Date: November 10, 2025

 

ATTACHMENTS / EXHIBITS

ALTERITY PRESENTS PROMISING ATH434 IMPACT AT AAS SYMPOSIUM

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Join the Fun to Win a $2,000 Vehicle Purchase Voucher and Amazon Gift Cards | KAIYI Auto Invites You to Celebrate the World’s Biggest Football Summer
• Hisense Celebrates FIFA World Cup 2026™ Kickoff with RGB MiniLED Innovation
• MaaS Giants Hit Billions?Tec-Do Unlocks AI Marketing's "ROI Closed-Loop"